Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104050 · ClinicalTrials.gov registry record · Phase 2
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2 study, sponsored by Olatec Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 202
- Enrollment target
NCT02104050 is a Phase 2 study that has completed, run by Olatec Therapeutics. The registered enrollment target is 202 participants.
The verdict
NCT02104050, a Phase 2 study, has completed, sponsored by Olatec Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 202 participants
- Enrollment target
Study Summary
The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.
Interventions
- DRUG Placebo Gel
- DRUG OLT1177 Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02104050
The ClinicalTrials.gov registry entry for NCT02104050 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olatec Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Gel is the first listed.
NCT02104050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02104050 about?
NCT02104050 is a clinical study titled "Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain". The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.
What is the current status of trial NCT02104050?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 202 participants. The study started on 2014-04. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02104050?
The interventions under investigation include: Placebo Gel (DRUG), OLT1177 Gel (DRUG).
Who is sponsoring clinical trial NCT02104050?
This trial is sponsored by Olatec Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.